Skip to Content

DepoDur Approval History

FDA Approved: Yes (Discontinued) (First approved May 18, 2004)
Brand name: DepoDur
Generic name: morphine sulfate
Dosage form: extended-release liposome Injection
Company: SkyePharma PLC and Endo Pharmaceuticals
Treatment for: Pain

Marketing Status: Discontinued

DepoDur (morphine sulfate extended-release liposome injection) is an opiate for the treatment of pain following major surgery.

Development History and FDA Approval Process for DepoDur

May 18, 2004Approval DepoDur SkyePharma PLC and Endo Pharmaceuticals - Treatment for Post-Surgical Pain Relief

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.